Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
15/03/2020 8:08 am
Bloodwork question about semax. Baseline, four months in, and the numbers moved in a direction I did not expect.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Anyone got a paper worth reading on this rather than a write-up of a paper?